Author Correction: Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group.
Gilles FreyerAnne FloquetOlivier TredanAurore CarrotCarole Langlois-JacquesJonathan LopezFrédéric SelleCyril AbdeddaimAlexandra LearyCoraline Dubot-PoitelonMichel FabbroLaurence GladieffMichele LamuragliaPublished in: Nature communications (2024)